SCHEMBL22475813

SCHEMBL22475813

CCn1cc2sc(CNc3nc(-c4cnn(CCO)c4)cnc3N)cc2n1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSF1R P07333 1/20 0.42
SYK P43405 1/20 0.40
MET P08581 5/20 0.37
ATR Q13535 1/20 0.37
MAPK1 P28482 1/20 0.36
FGFR1 P11362 6/20 0.36
FGFR3 P22607 6/20 0.36
KDR P35968 6/20 0.36
FGFR2 P21802 4/20 0.36
FGFR4 P22455 4/20 0.36
PIK3CD O00329 2/20 0.35
PIK3CA P42336 2/20 0.35
PIK3CB P42338 2/20 0.35
PI4KA P42356 2/20 0.35
PIK3CG P48736 2/20 0.35
PI4KB Q9UBF8 2/20 0.35
KIT P10721 1/20 0.35
EGFR P00533 1/20 0.35
FLT3 P36888 1/20 0.35
PDE3B Q13370 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23127929 0.89 CSF1R (0.53) CSF1RMETATRMAPK1FGFR1
SCHEMBL21167637 0.87 SYK (0.38) SYKMETFGFR1FGFR3KDR
SCHEMBL22475798 0.85 CSF1R (0.40) CSF1RSYKATRMAPK1FGFR1
SCHEMBL21167557 0.84 CSF1R (0.42) CSF1RSYKMETATRMAPK1
SCHEMBL21167558 0.79 CSF1R (0.41) CSF1RSYKMETATRFGFR1
SCHEMBL21167411 0.78 CSF1R (0.41) CSF1RSYKMETFGFR1FGFR3
SCHEMBL21167533 0.77 MET (0.45) CSF1RMETATRMAPK1PIK3CD
SCHEMBL16882483 0.76 MET (0.37) SYKMETFGFR1FGFR3KDR
SCHEMBL24591009 0.76 PIK3CD (0.35) CSF1RSYKMETMAPK1FGFR1
SCHEMBL12487424 0.75 MET (0.57) METPDE3BPDE3APDE4CPDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3511330-B1 SYNTHETIC INTERMEDIATE USEFUL IN THE PREPARATION OF TRIAZOLOPYRIDINE C-MET INHIBITORS HUTCHISON MEDIPHARMA LTD (CN) 2020-09-30 EP disclosed